Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade

Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade / cancer, classical Hodgkin lymphoma (cHL), Hematology.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.